Skip to main content
. 2003 Apr 1;88(7):1077–1083. doi: 10.1038/sj.bjc.6600776

Table 2. Correlation between clinicopathologic factors and expression of nuclear survivin in breast cancer.

  Nuclear survivin expression
  Negativea (n=154) Positiveb (n=139) P-value
Age (years)      
 ⩽60 93 89 n.s.
 >60 61 50  
       
Histological grade      
 I+II 75 79 n.s.
 III 79 60  
       
Lymph node status      
 Node − 76 88 n.s.
 Node + 78 51  
       
ER status      
 + (⩾10 fm mg−1) 96 99 n.s.
 − (<10 fm mg−1) 51 35  
 Unknown 7 5  
       
Tumour size (cm)      
 ⩽2.8 77 71 n.s.
 >2.8 77 68  
       
Adjuvant chemotherapy      
 Yes 76 70 n.s.
 No 68 64  
 Unknown 10 5  
       
Tamoxifen      
 Yes 91 73 n.s.
 No 51 60  
 Unknown 12 6  
a

⩽20% nuclear survivin expression.

b

>20% nuclear survivin expression. n.s.=not significant.